• Explore /
  • Poster
  • / Characterization of tumor antigen expression and myeloid immune profiles to inform the development of immune stimulating antibody conjugates (ISACs).

Characterization of tumor antigen expression and myeloid immune profiles to inform the development of immune stimulating antibody conjugates (ISACs).

Abstract Poster

Authors

null

Lisa K. Blum

Bolt Biotherapeutics, Redwood City, CA

Lisa K. Blum , Jason Ptacek , Heidi LeBlanc , William G. Mallet , Bruce A. Hug , Michael N. Alonso , Edith A. Perez , David Dornan , Marcin Kowanetz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Inflammatory Signatures

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2557)

DOI

10.1200/JCO.2022.40.16_suppl.2557

Abstract #

2557

Poster Bd #

212

Abstract Disclosures

Similar Posters

First Author: Laura Quan Man Chow

First Author: Ilana Mandel

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Genomic landscape of <em>ERBB2/3</em> alterations in colorectal cancer: Comutations, immuno-oncology biomarkers, and consensus molecular subtype.

Genomic landscape of ERBB2/3 alterations in colorectal cancer: Comutations, immuno-oncology biomarkers, and consensus molecular subtype.

First Author: Jeanne Tie

First Author: Jonathan Eliot Benjamin